Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Question

...

Panel
panelIconIdatlassian-note
panelIcon:note:
bgColor#DEEBFF

JSON File: ct_service_enrolment.json

Test Location

Questions

Concepts

What do you want to do?

🔘 Enrol a new client

🔘 Transfer in a client

🔘 Enrol a Mother into PMTCT program

🔘 Re-enrol a client

166937 Care management plan

Enrolment Date

␣␣-␣␣-␣␣␣␣ 📆

160555 Date enrolled in HIV care

Unique ID

__________________________________

162576 New patient identifier

Other Unique ID

__________________________________

162727 Other facility patient identifier

Entry Point

🔽 Voluntary male circumcision clinic

🔽 Private home-based care

🔽 Adolescent outreach program

🔽 Private Company

🔽 Outreach program

🔽 Community-based organization

🔽 Outpatient department

🔽 Pediatric inpatient service

🔽 Voluntary counseling and testing program

🔽 Maternal and child health program

🔽 Vaccination service

🔽 Nutrition program

🔽 Sex worker outreach program

🔽 Intravenous venous drug user outreach program

🔽 Sexually transmitted infection program/clinic

🔽 Under five clinic

🔽 Tuberculosis treatment program

🔽 Adult inpatient service

160540 Method of enrollment

Entry Point - Other

__________________________________

61011 Free text comment

Population Category

🔘 General population

🔘 Key population

🔘 Priority population

166432 Study population type

Key Population Type

🔘 Intravenous drug user

🔘 Male who has sex with men

🔘 Prisoners

🔘 Sex worker

🔘 Transgender Persons

166433 Target population type

Priority Population Type

🔽 Adolescent Girls & Young Women

🔽 Client of sex worker

🔽 Fisher Folk

🔽 Long-distance truck driver

🔽 Migrant Workers

🔽 Non-intravenous drug user

🔽 Refugee

🔽 Uniformed Forces

🔽 Other

166433 Target population type

Transfer-In

Transferring Facility

__________________________________

160535 Transferred from location

Start ART Date

␣␣-␣␣-␣␣␣␣ 📆

Current ART Regimen

🔽

🔽

🔽

🔽

🔽

Transfer Documents

Transfer Documents

🔘 Mother enrolled in prevention of maternal to child transmission (PMTCT) program

🔘 Transfer-in with Records

🔘 Transfer-in without records159599 Antiretroviral treatment start date

Regimen

🔽 ABC + 3TC + DTG
🔽 ABC + 3TC + EFV
🔽 ABC + 3TC + LPV/r
🔽 ABC + 3TC + NVP
🔽 AZT + 3TC + ATV/r
🔽 AZT + 3TC + DTG
🔽 AZT + 3TC + EFV
🔽 AZT + 3TC + LPV/r
🔽 AZT + 3TC + NVP
🔽 DRV/r + DTG + ABC + 3TC
🔽 DRV/r + DTG + AZT + 3TC
🔽 DRV/r + DTG + TDF + 3TC
🔽 DRV/r + RAL + AZT + 3TC
🔽 DRV/r + RAL + ABC + 3TC
🔽 DRV/r + RAL + TDF + 3TC
🔽 TDF + 3TC + ATV/r
🔽 TDF + 3TC + DTG
🔽 TDF + 3TC + EFV
🔽 TDF + 3TC + LPV/r
🔽 TDF + 3TC + NVP

164432 ARV regimen/code for drugs collected

Date of Enrolment into HIV Care

␣␣-␣␣-␣␣␣␣ 📆

163260 Date of first visit

HIV Diagnosis

Date Confirmed HIV Positive

␣␣-␣␣-␣␣␣␣ 📆

160554 Date of HIV diagnosis

Test Type

🔘 Rapid test for HIV

🔘 HIV DNA polymerase chain reaction

🔘 Unknown

Test Location

__________________________________164401 HIV test performed

Previous ARV/HAART Use

Indication/intent of therapy

☑️ Pre Exposure Prophylaxis (PrEP)

☑️ Prevention of Mother to Child Transmission (PMTCT)

☑️ Post-exposure prophylaxis (PEP)

160846 Indication/intent of therapy

Use of Pre Exposure Prophylaxis (PrEP)
🔘 Yes
🔘 No
🔘 Unknown

Date Last Used

␣␣-␣␣-␣␣␣␣ 📆166655 Pre-exposure prophylaxis (PrEP) regimen
1065 Yes

1066 No

1067 Unknown

Use of Post-exposure prophylaxis (PEP)***CC
🔘 Yes
🔘 No
🔘 Unknown

Date Last Used

␣␣-␣␣-␣␣␣␣ 📆

ARV Use for Management of Hepatitis

🔘 Yes

🔘 No

🔘 Unknown

Date Last Used

␣␣-␣␣-␣␣␣␣ 📆

164845 Eligible for post-exposure prophylaxis
1065 Yes

1066 No

1067 Unknown

ART Use for Prevention of Mother to Child Transmission of HIV***CC
🔘 Yes
🔘 No
🔘 Unknown

Date Last Used

␣␣-␣␣-␣␣␣␣ 📆

163532 Mother enrolled in prevention of maternal to child transmission (PMTCT) program
1065 Yes

1066 No

1067 Unknown

Nucleoside Reverse Transcriptase Inhibitors (NRTIS)***CC
☑️ Zidovudine
☑️ Tenofovir
☑️ Lamivudine
☑️ Emtricitabine
☑️ Abacavir
☑️ Other antiretroviral drug

NRTIS Nucleoside Reverse Transcriptase Inhibitors (NRTIS

🔽

🔽

🔽

🔽

🔽

) ARVs
86663 Zidovudine

84796 Tenofovir disoproxil

78643 Lamivudine

75628 Emtricitabine

70056 Abacavir

5424 Other antiretroviral drug

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)***CC
☑️ Etravirine
☑️ Nevirapine
☑️ Efavirenz
☑️ Other antiretroviral drug
☑️ Unknown

NNRTIS Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) ARVs
🔽 159810 Etravirine🔽

80586 Nevirapine

🔽

🔽

🔽 75523 Efavirenz

5424 Other antiretroviral drug

1067 Unknown

Protease Inhibitors (PIS)

🔽

🔽

🔽

🔽

🔽 ***CC
☑️ Tipranavir
☑️ Saquinavir
☑️ Ritonavir
☑️ Fosamprenavir
☑️ Darunavir
☑️ Atazanavir

ProteaseInhibitorsProtease Inhibitors (PIS) ARVs
85160 Tipranavir

83690 Saquinavir

83412 Ritonavir

76658 Fosamprenavir

74258 Darunavir

71647 Atazanavir

Other HIV Drug Classes

🔽

🔽

🔽

🔽

🔽

Treatment Supporter

Treatment Supporter Available

🔘 Yes

🔘 No


☑️ Raltegravir
☑️ Dolutegravir
☑️ Maraviroc
☑️ Enfuvirtide
☑️ Other antiretroviral drug
☑️ Unknown

1193 Current drugs used
154378 Raltegravir

165085 Dolutegravir

154376 Maraviroc

75676 Enfuvirtide

5424 Other antiretroviral drug

1067 Unknown

Treatment Supporter

Treatment Supporter Name

__________________________________

160638 Name of treatment supporter

Treatment Supporter Phone Number

__________________________________

160642 Telephone number of treatment supporter

Treatment Supporter Relationship

🔽 Sibling

🔽 Parent

🔽 Partner or spouse

🔽 Guardian

🔽 Grandparent

🔽 Other

160640 Treatment supporter relationship to patient

Re-enrollment

Date of Re-enrollment

␣␣-␣␣-␣␣␣␣ 📆

160753 Date of event

Reason For Re-enrolment

__________________________________

160632 Free text general